Changes in 5-HT4 receptor and 5-HT transporter binding in olfactory bulbectomized and glucocorticoid receptor heterozygous mice

Neurochemistry International

Volumn 56, Issue 4, 2010, Pages 603-610

  Licht, Cecilie L ^a   Kirkegaard, Lisbeth ^a   Zueger, Maha ^b   Chourbaji, Sabine ^b   Gass, Peter ^b   Aznar, Susana ^a   Knudsen, Gitte M ^a  

^a Rigshospitalet   (Denmark)

^b UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Depression; Hippocampus; Mouse; Serotonin 4 receptor; Serotonin transporter; Striatum

Indexed keywords

CITALOPRAM; GLUCOCORTICOID RECEPTOR; PARGYLINE; SEROTONIN 4 RECEPTOR; SEROTONIN TRANSPORTER; DIAGNOSTIC AGENT; PIPERIDINE DERIVATIVE; SB 207145; SEROTONIN UPTAKE INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; BINDING AFFINITY; CAUDATE NUCLEUS; CONTROLLED STUDY; DEPRESSION; GLOBUS PALLIDUS; HIPPOCAMPUS; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MALE; MOUSE; NONHUMAN; OLFACTORY BULB; OLFACTORY BULBECTOMY; OPEN FIELD TEST; PRIORITY JOURNAL; PUTAMEN; RECEPTOR BINDING; ANIMAL; BRAIN LEVEL; C57BL MOUSE; GENETICS; IMAGE PROCESSING; METABOLISM; MOTOR ACTIVITY; MOUSE MUTANT; PHYSIOLOGY; PROTEIN BINDING;

MURINAE; MUS;

ANIMALS; AUTORADIOGRAPHY; BRAIN CHEMISTRY; CITALOPRAM; IMAGE PROCESSING, COMPUTER-ASSISTED; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MOTOR ACTIVITY; OLFACTORY BULB; PIPERIDINES; PROTEIN BINDING; RECEPTORS, GLUCOCORTICOID; RECEPTORS, SEROTONIN, 5-HT4; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; SEROTONIN UPTAKE INHIBITORS;

EID: 77249146374     PISSN: 01970186     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuint.2010.01.003     Document Type: Article

References (57)

1. 4 receptors in neurons. Eur. J. Pharmacol. 298 (1996) 165-174
2. Ballaz S.J., Akil H., and Watson S.J. Analysis of 5-HT6 and 5-HT7 receptor gene expression in rats showing differences in novelty-seeking behavior. Neuroscience 147 (2007) 428-438
3. Bannerman D.M., Rawlins J.N., McHugh S.B., Deacon R.M., Yee B.K., Bast T., Zhang W.N., Pothuizen H.H., and Feldon J. Regional dissociations within the hippocampus-memory and anxiety. Neurosci. Biobehav. Rev. 28 (2004) 273-283
4. 4 receptor activation. Naunyn. Schmiedebergs Arch. Pharmacol. 363 (2001) 491-498
5. Cahir M., Ardis T., Reynolds G.P., and Cooper S.J. Acute and chronic tryptophan depletion differentially regulate central 5-HT1A and 5-HT 2A receptor binding in the rat. Psychopharmacology (Berl.) 190 (2007) 497-506
6. Cairncross K.D., Cox B., Forster C., and Wren A. The ability of local injection of 6-OHDA, 5,6-DHT and 5,7-DHT into the olfactory bulbs to mimic the effects of bilateral bulbectomy in the rat. Br. J. Pharmacol. 61 (1977) 145P-146P
7. Cairncross K.D., Wren A., Cox B., and Schnieden H. Effects of olfactory bulbectomy and domicile on stress-induced corticosterone release in the rat. Physiol. Behav. 19 (1977) 485-487
8. Chourbaji S., and Gass P. Glucocorticoid receptor transgenic mice as models for depression. Brain Res. Rev. 57 (2008) 554-560
9. Claeysen S., Sebben M., Journot L., Bockaert J., and Dumuis A. Cloning, expression and pharmacology of the mouse 5-HT(4L) receptor. FEBS Lett. 398 (1996) 19-25
10. 4 receptors: cloning and expression of new splice variants. Ann. N. Y. Acad. Sci. 861 (1998) 49-56
11. 4 receptor splice variants show marked constitutive activity: role of the C-terminal intracellular domain. Mol. Pharmacol. 55 (1999) 910-920
12. 4 receptors in rat basal ganglia and hippocampus. Eur. J. Neurosci. 8 (1996) 2591-2598
13. Compan V., Segu L., Buhot M.C., and Daszuta A. Selective increases in serotonin 5-HT1B/1D and 5-HT2A/2C binding sites in adult rat basal ganglia following lesions of serotonergic neurons. Brain Res. 793 (1998) 103-111
14. Compan V., Segu L., Buhot M.C., and Daszuta A. Differential effects of serotonin (5-HT) lesions and synthesis blockade on neuropeptide-Y immunoreactivity and 5-HT1A, 5-HT1B/1D and 5-HT2A/2C receptor binding sites in the rat cerebral cortex. Brain Res. 795 (1998) 264-276
15. 4 receptor knock-out mice. J. Neurosci. 24 (2004) 412-419
16. Garris D.R., Chamberlain J.K., and DaVanzo J.P. Histofluorescent identification of indoleamine-concentrating brain loci associated with intraspecies, reflexive biting and locomotor behavior in olfactory-bulbectomized mice. Brain Res. 294 (1984) 385-389
17. Grecksch G., Zhou D., Franke C., Schroder U., Sabel B., Becker A., and Huether G. Influence of olfactory bulbectomy and subsequent imipramine treatment on 5-hydroxytryptaminergic presynapses in the rat frontal cortex: behavioural correlates. Br. J. Pharmacol. 122 (1997) 1725-1731
18. Gurevich E.V., Aleksandrova I.A., Otmakhova N.A., Katkov Y.A., Nesterova I.V., and Bobkova N.V. Effects of bulbectomy and subsequent antidepressant treatment on brain 5-HT2 and 5-HT1A receptors in mice. Pharmacol. Biochem. Behav. 45 (1993) 65-70
19. Hasler G., Drevets W.C., Manji H.K., and Charney D.S. Discovering endophenotypes for major depression. Neuropsychopharmacology 29 (2004) 1765-1781
20. Heal D.J., Philpot J., Molyneux S.G., and Metz A. Intracerebroventricular administration of 5,7-dihydroxytryptamine to mice increases both head-twitch response and the number of cortical 5-HT2 receptors. Neuropharmacology 24 (1985) 1201-1205
21. Hellweg R., Zueger M., Fink K., Hortnagl H., and Gass P. Olfactory bulbectomy in mice leads to increased BDNF levels and decreased serotonin turnover in depression-related brain areas. Neurobiol. Dis. 25 (2007) 1-7
22. Heuser I., Yassouridis A., and Holsboer F. The combined dexamethasone/CRH test: a refined laboratory test for psychiatric disorders. J. Psychiatr. Res. 28 (1994) 341-356
23. Huether G., Zhou D., and Ruther E. Long-term modulation of presynaptic 5-HT-output: experimentally induced changes in cortical 5-HT-transporter density, tryptophan hydroxylase content and 5-HT innervation density. J. Neural Transm. 104 (1997) 993-1004
24. Ikemoto S. Involvement of the olfactory tubercle in cocaine reward: intracranial self-administration studies. J. Neurosci. 23 (2003) 9305-9311
25. Ikemoto S. Dopamine reward circuitry: two projection systems from the ventral midbrain to the nucleus accumbens-olfactory tubercle complex. Brain Res. Rev. 56 (2007) 27-78
26. 3H]BIMU-1. Neuropharmacology 33 (1994) 1027-1038
27. Jarosik J., Legutko B., Unsicker K., and von Bohlen Und Halbach O. Antidepressant-mediated reversal of abnormal behavior and neurodegeneration in mice following olfactory bulbectomy. Exp. Neurol. 204 (2007) 20-28
28. Kelly J.P., Wrynn A.S., and Leonard B.E. The olfactory bulbectomized rat as a model of depression: an update. Pharmacol. Ther. 74 (1997) 299-316
29. Kornetsky C., Huston-Lyons D., and Porrino L.J. The role of the olfactory tubercle in the effects of cocaine, morphine and brain-stimulation reward. Brain Res. 541 (1991) 75-81
30. 4 receptor binding is down-regulated in the Flinders Sensitive Line depression model and in response to paroxetine administration. J. Neurochem. 109 (2009) 1363-1374
31. 4 receptors exert a frequency-related facilitatory control on dorsal raphe nucleus 5-HT neuronal activity. Eur. J. Neurosci. 16 (2002) 817-822
32. 4 agonists. Biol. Psychiatry 57 (2005) 918-925
33. Lucas G., Rymar V.V., Du J., Mnie-Filali O., Bisgaard C., Manta S., Lambas-Senas L., Wiborg O., Haddjeri N., Pineyro G., Sadikot A.F., and Debonnel G. Serotonin(4) (5-HT(4)) receptor agonists are putative antidepressants with a rapid onset of action. Neuron 55 (2007) 712-725
34. McLean J.H., and Shipley M.T. Serotonergic afferents to the rat olfactory bulb. I. Origins and laminar specificity of serotonergic inputs in the adult rat. J. Neurosci. 7 (1987) 3016-3028
35. Meijer O.C., Cole T.J., Schmid W., Schutz G., Joels M., and De Kloet E.R. Regulation of hippocampal 5-HT1A receptor mRNA and binding in transgenic mice with a targeted disruption of the glucocorticoid receptor. Brain Res. Mol. Brain Res. 46 (1997) 290-296
36. Murray C.J., and Lopez A.D. Alternative projections of mortality and disability by cause 1990-2020: global burden of disease study. Lancet 349 (1997) 1498-1504
37. Neckers L.M., Zarrow M.X., Myers M.M., and Denenberg V.H. Influence of olfactory bulbectomy and the serotonergic system upon intermale aggression and maternal behavior in the mouse. Pharmacol. Biochem. Behav. 3 (1975) 545-550
38. Nesterova I.V., Gurevich E.V., Nesterov V.I., Otmakhova N.A., and Bobkova N.V. Bulbectomy-induced loss of raphe neurons is counteracted by antidepressant treatment. Prog. Neuropsychopharmacol. Biol. Psychiatry 21 (1997) 127-140
39. Ohtsuki T., Ishiguro H., Detera-Wadleigh S.D., Toyota T., Shimizu H., Yamada K., Yoshitsugu K., Hattori E., Yoshikawa T., and Arinami T. Association between serotonin 4 receptor gene polymorphisms and bipolar disorder in Japanese case-control samples and the NIMH Genetics Initiative Bipolar Pedigrees. Mol. Psychiatry 7 (2002) 954-961
40. Paxinos G., and Franklin K.B.J. The Mouse Brain in Stereotaxic Coordinates. second ed. (2001), Academic Press, San Diego
41. Ridder S., Chourbaji S., Hellweg R., Urani A., Zacher C., Schmid W., Zink M., Hortnagl H., Flor H., Henn F.A., Schutz G., and Gass P. Mice with genetically altered glucocorticoid receptor expression show altered sensitivity for stress-induced depressive reactions. J. Neurosci. 25 (2005) 6243-6250
42. 4 postsynaptic receptors and their intracellular signalling systems IP3 and cAMP in brains from depressed violent suicide victims. Neuropsychobiology 49 (2004) 189-195
43. 3H]paroxetine. J. Neurochem. 52 (1989) 1605-1612
44. Schulte-Herbruggen O., Hellweg R., Chourbaji S., Ridder S., Brandwein C., Gass P., and Hortnagl H. Differential regulation of neurotrophins and serotonergic function in mice with genetically reduced glucocorticoid receptor expression. Exp. Neurol. 204 (2007) 307-316
45. Sharp T., Boothman L., Raley J., and Queree P. Important messages in the 'post': recent discoveries in 5-HT neurone feedback control. Trends Pharmacol. Sci. 28 (2007) 629-636
46. Shipley M.T., and Adamek G.D. The connections of the mouse olfactory bulb: a study using orthograde and retrograde transport of wheat germ agglutinin conjugated to horseradish peroxidase. Brain Res. Bull. 12 (1984) 669-688
47. Slotkin T.A., Cousins M.M., Tate C.A., and Seidler F.J. Serotonergic cell signaling in an animal model of aging and depression: olfactory bulbectomy elicits different adaptations in brain regions of young adult vs aging rats. Neuropsychopharmacology 30 (2005) 52-57
48. Song C., and Leonard B.E. The olfactory bulbectomised rat as a model of depression. Neurosci. Biobehav. Rev. 29 (2005) 627-647
49. Trajkovska V., Kirkegaard L., Krey G., Marcussen A.B., Thomsen M.S., Chourbaji S., Brandwein C., Ridder S., Halldin C., Gass P., Knudsen G.M., and Aznar S. Activation of glucocorticoid receptors increases 5-HT2A receptor levels. Exp. Neurol. 218 (2009) 83-91
50. Tronche F., Kellendonk C., Kretz O., Gass P., Anlag K., Orban P.C., Bock R., Klein R., and Schutz G. Disruption of the glucocorticoid receptor gene in the nervous system results in reduced anxiety. Nat. Genet. 23 (1999) 99-103
51. 4 receptor-dependent signalling and functionality in rat brain. J. Neurochem. 110 (2009) 1120-1127
52. 4 receptors and their mRNAs in rat and guinea pig brain: distribution and effects of neurotoxic lesions. J. Comp. Neurol. 484 (2005) 418-439
53. 4 binding sites in rodent brain. Neuropharmacology 33 (1994) 527-541
54. Watanabe A., Tohyama Y., Nguyen K.Q., Hasegawa S., Debonnel G., and Diksic M. Regional brain serotonin synthesis is increased in the olfactory bulbectomy rat model of depression: an autoradiographic study. J. Neurochem. 85 (2003) 469-475
55. Wrynn A.S., Mac Sweeney C.P., Franconi F., Lemaire L., Pouliquen D., Herlidou S., Leonard B.E., Gandon J., and de Certaines J.D. An in-vivo magnetic resonance imaging study of the olfactory bulbectomized rat model of depression. Brain Res. 879 (2000) 193-199
56. Zhou D., Grecksch G., Becker A., Frank C., Pilz J., and Huether G. Serotonergic hyperinnervation of the frontal cortex in an animal model of depression, the bulbectomized rat. J. Neurosci. Res. 54 (1998) 109-116
57. Zueger M., Urani A., Chourbaji S., Zacher C., Roche M., Harkin A., and Gass P. Olfactory bulbectomy in mice induces alterations in exploratory behavior. Neurosci. Lett. 374 (2005) 142-146